Clinical Certificate


Date: Thursday 30th April 2020 – Friday 1st May 2020
Venue: Victoria and Albert Hotel, Water St, Manchester, M3 4JQ
Accommodation: Victoria and Albert Hotel, Water St, Manchester, M3 4JQ
(accommodation is bookable separately when you complete the online booking form)
Organised by: Professor Jo Neill and Dr Richard Drake


Programme to be confirmed

Last edited 24th October 2019

Learning Objectives

At the end of this module, the attendees will:

  • Be aware of current theories of the causes and neurochemistry of schizophrenia
  • Know the pharmacology of conventional and atypical drugs
  • Be aware of the clinical assessment of therapeutic and adverse effects
  • Have an opinion about relative benefits of conventional and atypical drugs
  • Be updated on guidelines and the social context of drug prescribing in schizophrenia
  • Have had an opportunity to discuss difficult management problems with colleagues and experts

This module is eligible for 11 CPD hours which are subject to peer group review.

For further details contact Susan Chandler, BAP Executive Officer:

Feedback from 2019 Module

"Excellent course. Really well organised and a great atmosphere for learning. Lovely food and I learnt so much. Very good value for money – BAP runs the best courses around!"

"Excellently organised meeting, clinically applicable and kudos to presenters and organisers"

"Thank you for an excellent course, I will recommend to colleagues"

"Really enjoyable and insightful, I have learnt a lot and it was highly relevant/practical to my clinical work"